Xeris Biopharma Holdings Inc Live Stock Price Today, Share Analysis and Chart

Name: Xeris Biopharma Holdings Inc: Is Infosys Ltd. worth buying?
Item: Xeris Biopharma Holdings Inc
Rating: 2.14650
Author: Trendlyne DVM scores

about

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrom...

7.99 0.04 (0.50%)

New 52W High today

2.3M

XNAS Volume

XNAS 27 Aug, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

9.0 / 100

Technically Bullish

76.9 / 100

1Yr Price target upside is 13%

6 analysts

Xeris Biopharma Holdings Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Xeris Biopharma Holdings Inc Live Stock Price Today, Share Analysis and Chart

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrom...

New 52W High today

SWOT Analysis

Xeris Biopharma Holdings Inc Live Price Chart